Skip to main content
. 2022 Jan 3;16(3):462–473. doi: 10.1111/irv.12929

FIGURE 1.

FIGURE 1

Study design. FLU‐PRO, InFLUenza Patient Reported Outcome; RSV, respiratory syncytial virus